Clinical

Dataset Information

0

Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients


ABSTRACT: The goal of this clinical trial] is to compare in resectable stage T3-4N2 colorectal cancer. The main question it aims to answer is: whether the use of targeted therapy in combination with adjuvant chemotherapy is associated with improved disease-free survival (DFS) compared to adjuvant chemotherapy alone.

DISEASE(S): Chemotherapy Effect,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 13676 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2018-09-11 | PXD009254 | Pride
| 13646 | ecrin-mdr-crc
| PRJNA1012702 | ENA
| PRJNA170959 | ENA
2019-09-13 | GSE137356 | GEO
2021-03-31 | GSE154156 | GEO
| PRJEB35624 | ENA
2016-01-20 | E-MTAB-3696 | biostudies-arrayexpress
| phs001365 | dbGaP
| 46513 | ecrin-mdr-crc